title: [COMMENTS ON FRENCH RECOMMENDATIONS ON GLYCEMIC CONTROL IN TYPE 2 DIABETES].
abstract: The French guidelines recently changed after that several studies highlighted that normoglycemia was not an acceptable target for everyone. Normoglycemia can be only recommended at the beginning of diabetes, using metformin as treatment. But later, targeting an HbA1c < 7% is a good objective, except in patients with a severe cardiovascular disease: in that case, an HbAlc <8% without hypoglycemia is reasonable. In old patients with severe comorbidities, a comfortable objective is an HbA1c <9%. After melformine use, sulfoaylurea may he used as the second line treatment DPP-4 inhibitors are the third line treatment GLP-1 analogs have to be kept for patients with complicated overweight and an HbA1c above 1% over target
authors.forename: Agnès
authors.initials: A
authors.lastname: Hartemann
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000628:therapy*; D004359:Drug Therapy, Combination; D005602:France; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D017410:Practice Guidelines as Topic
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; C517652:hemoglobin A1c protein, human